Main features of DNA-based immunization vectors (Q33646629)

28 July 2017

1 reference

title

Main features of DNA-based immunization vectors (English)

1 reference

28 July 2017

V Azevedo

1

1 reference

28 July 2017

G Levitus

2

1 reference

28 July 2017

A Miyoshi

3

1 reference

28 July 2017

A L Cândido

4

1 reference

28 July 2017

A M Goes

5

1 reference

28 July 2017

S C Oliveira

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Brazilian Journal of Medical and Biological Research

28 July 2017

published in

1 reference

28 July 2017

volume

32

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

147-153

1 reference

Plasmid DNA expression systems for the purpose of immunization

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Promoter-regulatory region of the major immediate early gene of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

The cytomegalovirus enhancer: a pan-active control element in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Activity assays of nine heterogeneous promoters in neural and other cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Development of improved vectors for DNA-based immunization and other gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Myosin regulatory elements as vectors for gene transfer by intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Introns increase transcriptional efficiency in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Do the poly(A) tail and 3' untranslated region control mRNA translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Immune responses to nucleic acid vaccines to rabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Protection against mycoplasma infection using expression-library immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1999000200002

10.1590/S0100-879X1999000200002

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference